BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19240005)

  • 1. [Guillain Barré syndrome in pediatrics].
    Erazo Torricelli R
    Medicina (B Aires); 2009; 69(1 Pt 1):84-91. PubMed ID: 19240005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of Guillain-Barre syndrome in children: results from a Mexican population.
    Nachamkin I; Arzarte Barbosa P; Ung H; Lobato C; Gonzalez Rivera A; Rodriguez P; Garcia Briseno A; Cordero LM; Garcia Perea L; Perez JC; Ribera M; Aldama PC; Guitérrez GD; Sarnat LF; García MR; Veitch J; Fitzgerald C; Cornblath DR; Rodriguez Pinto M; Griffin JW; Willison HJ; Asbury AK; McKhann GM
    Neurology; 2007 Oct; 69(17):1665-71. PubMed ID: 17898327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological subtypes and prognosis of childhood Guillain-Barré syndrome in Japan.
    Nagasawa K; Kuwabara S; Misawa S; Fujii K; Tanabe Y; Yuki N; Hattori T; Kohno Y
    Muscle Nerve; 2006 Jun; 33(6):766-70. PubMed ID: 16506153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and prognosis of childhood Guillain-Barré syndrome.
    Lee JH; Sung IY; Rew IS
    J Paediatr Child Health; 2008; 44(7-8):449-54. PubMed ID: 18557809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré syndrome: an update.
    Vucic S; Kiernan MC; Cornblath DR
    J Clin Neurosci; 2009 Jun; 16(6):733-41. PubMed ID: 19356935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sural-sparing is seen in axonal as well as demyelinating forms of Guillain-Barré syndrome.
    Umapathi T; Li Z; Verma K; Yuki N
    Clin Neurophysiol; 2015 Dec; 126(12):2376-80. PubMed ID: 25743269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.
    Yuki N; Kuwabara S
    J Peripher Nerv Syst; 2007 Dec; 12(4):238-49. PubMed ID: 18042134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain-Barré syndrome.
    Kannan MA; Ch RK; Jabeen SA; Mridula KR; Rao P; Borgohain R
    Neurol India; 2011; 59(5):727-32. PubMed ID: 22019659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome.
    Arcila-Londono X; Lewis RA
    Semin Neurol; 2012 Jul; 32(3):179-86. PubMed ID: 23117942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Guillain-Barré syndrome.
    Fujimura H
    Handb Clin Neurol; 2013; 115():383-402. PubMed ID: 23931791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Guillain-Barré syndrome in childhood].
    Kollár K; Liptai Z; Rosdy B; Móser J
    Ideggyogy Sz; 2009 Nov; 62(11-12):399-404. PubMed ID: 20025130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miller Fisher syndrome: toward a more comprehensive understanding.
    Li H; Yuan J
    Chin Med J (Engl); 2001 Mar; 114(3):235-9. PubMed ID: 11780304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired inflammatory demyelinating neuropathies.
    Ensrud ER; Krivickas LS
    Phys Med Rehabil Clin N Am; 2001 May; 12(2):321-34, ix. PubMed ID: 11345010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome.
    Hughes RA; Cornblath DR
    Lancet; 2005 Nov; 366(9497):1653-66. PubMed ID: 16271648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving pattern of Guillain-Barre syndrome in a community hospital in Israel.
    Kushnir M; Klein C; Pollak L; Rabey JM
    Acta Neurol Scand; 2008 May; 117(5):347-50. PubMed ID: 17995988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guillain-Barre syndrome and its frontiers].
    Azulay JP; Verschueren A; Attarian S; Pouget J
    Rev Neurol (Paris); 2002 Dec; 158(12 Pt 2):S21-6. PubMed ID: 12690657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
    St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
    J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.